Trump’s China Financial Decoupling Move Has Roots in Enron Saga
- White House reviewing regulator dispute over access to audits
- Administration hard-liners aim to curb capital flows to China
This article is for subscribers only.
Terms of Trade is a daily newsletter that untangles a world embroiled in trade wars. Sign up here.
Rising tensions between Washington and Beijing have prompted some White House officials to fixate on a provocative question with big implications for global markets: Why can Chinese companies sell shares in the U.S. when American regulators are barred from inspecting their books?